Clinical Trial Update: A Study of MK0364 in Obese Patients (0364-014) [Phase 3]

View source ↗

Summary

Update on a Phase 3 trial of MK0364 in obese patients; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• MK0364

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 3 | Status: TERMINATED